OBIO icon

Orchestra BioMed
OBIO

Overview Fund Activity

46 hedge funds and large institutions have $130M invested in Orchestra BioMed in 2021 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 7 closing their positions.

Holders
46
Holders Change
–
Holders Change %
0%
% of All Funds
0.81%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
7
Increased
7
Reduced
4
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
AC
1
Amitell Capital
Singapore
$5.36M
2
IC
2
Ikarian Capital
Texas
$2.25M
3
DKCM
3
Davidson Kempner Capital Management
New York
$6.96M
4
AC
4
Athanor Capital
New York
$669K
5
AAA
5
Affinity Asset Advisors
New York
$2.52M

Top Sellers

1
AIC
1
AWM Investment Company
New York
$0
2
Wellington Management Group
2
Wellington Management Group
Massachusetts
$7.17M
3
GL
3
Governors Lane
New York
$0
4
KPF
4
K2 Principal Fund
Ontario, Canada
$726K
5
PC
5
Periscope Capital
Ontario, Canada
$0
Name Market Value Shares Shares
Change 		Shares
Change %
HI
51
HBK Investments
Texas
– – -47,800 Closed
ECM
52
ExodusPoint Capital Management
New York
– – -29,800 Closed
OWP
53
Old Well Partners
North Carolina
– – -14,300 Closed
CFGS
54
Concourse Financial Group Securities
Alabama
– – – –
1 2
3